Pregnancy Myths and Practical Tips

Rebecca Caro, DO
Julia Fast, DO

American Family Physician. 2020;102(7):420-426.

Author disclosure: No relevant financial affiliations.

For many patients, pregnancy is a highly anticipated and exciting phase of life, but it can also be anxiety provoking. Family physicians can resolve some of this anxiety and promote maternal and fetal health by making specific recommendations at prenatal visits. A daily prenatal vitamin with at least 400 mcg of folic acid and 30 mg of elemental iron should be recommended to promote neurologic and musculoskeletal fetal development. Weight gain in pregnancy should be guided by preconception body mass index. People who are underweight should gain 28 to 40 lb, those who have a normal weight should gain 25 to 35 lb, and those who are overweight or obese should gain 15 to 25 lb or 11 to 20 lb, respectively. A well-balanced diet including omega-3 fatty acids should be encouraged. Unpasteurized foods should be avoided during pregnancy because of the risk of listeriosis. Caffeine intake should be limited to 200 mg per day (about two small cups of coffee), and artificial sweeteners should be avoided. Pregnant patients should be encouraged to engage in regular cardiovascular activity for at least 150 minutes per week. Bed rest is not recommended. Sex can be continued throughout an uncomplicated pregnancy. Avoidance of alcohol and marijuana is recommended. The effects of hair dye or hair straightening products on fetal development or neonatal outcomes are unclear.

In 2016, prenatal care was initiated in the first trimester in more than 75% of pregnancies,1 providing a multitude of opportunities for family physicians to counsel these patients on the basics of a healthy pregnancy. During prenatal visits, physicians can dispel many myths about pregnancy. This article will discuss physical activity, provide recommendations for weight gain during pregnancy, review components of a well-balanced diet, discuss supplement and medication use, and dispel myths related to topics that have traditionally been taboo: sex and the use of marijuana and alcohol during pregnancy. Communicating this information in an individualized manner will promote maternal and fetal health.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating Comments
Weight gain during pregnancy should be individualized based on prepregnancy body mass index.26 C Systematic review, cohort study, and guidelines showing that early weight gain and maternal obesity are associated with higher infant mortality
Unpasteurized foods should not be consumed during pregnancy.7,8 C Practice recommendations and analysis showing poor neonatal outcomes in patients with listeriosis
A prenatal vitamin with folic acid, vitamin D, calcium, and iron should be recommended for pregnant patients.1,3,4,9 A Meta-analyses and systematic reviews showing decreased fetal neural tube defects and promotion of musculoskeletal development
Instead of routinely being given a fish oil supplement, pregnant patients should be encouraged to consume two or three servings per week of fish that contains low levels of mercury.3,11 B Randomized controlled trials showing that high fish consumption decreases preterm birth, observational studies showing increased neurodevelopment in children, and expert opinion/usual practice
Pregnant patients should be encouraged to engage in moderate-intensity exercise for at least 150 minutes per week.15,16,19,20 B Systematic review and meta-analyses showing fewer newborn complications and maternal health benefits
Alcohol should not be consumed during pregnancy.36,37 C Case-control study showing risk of fetal alcohol spectrum disorder and lower birth weight
Caffeine intake should be limited to 200 mg per day during pregnancy.41,42 A Meta-analyses showing increased early pregnancy loss with high doses of caffeine

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

BEST PRACTICES IN MATERNITY CARE

Recommendations from the Choosing Wisely Campaign
RecommendationSponsoring organization
Do not place patients, even those at high risk, on activity restriction to prevent preterm birth.Society for Maternal-Fetal Medicine
Do not routinely recommend activity restriction or bed rest during pregnancy for any indication.American College of Obstetricians and Gynecologists

Source: For more information on the Choosing Wisely Campaign, see https://www.choosingwisely.org. For supporting citations and to search Choosing Wisely recommendations relevant to primary care, see https://www.aafp.org/afp/recommendations/search.htm.

Weight Gain and Diet

The National Academy of Medicine recommends that weight gain during pregnancy be based on preconception body mass index (Table 1).2 Patients should be counseled that pregnancy does not require doubling caloric intake.2 Weight goals should be individualized according to the baseline fitness level, prepregnancy weight, and other metabolic considerations. A safe recommendation is 350 to 450 calories per day above the previous intake3 (e.g., two slices of bread with half an avocado, ¾ cup of Greek yogurt or 1 cup of blueberries with two hard-boiled eggs). These recommendations optimize birth weight and minimize adverse pregnancy outcomes.2,4 Excessive weight gain and preexisting maternal obesity are associated with increased antepartum complications, including fetal death, stillbirth, and neonatal death5,6 (Table 25 ).

TABLE 1. Recommended Weight Gain During Pregnancy

Prepregnancy body mass index (kg per m2)CategoryRecommended weight gain
< 18.5Underweight28 to 40 lb (12.7 to 18.1 kg)
18.5 to 24.9Normal weight25 to 35 lb (11.3 to 15.9 kg)
25.0 to 29.9Overweight15 to 25 lb (6.8 to 11.3 kg)
≥ 30Obese11 to 20 lb (5.0 to 9.1 kg)

Adapted with permission from Institute of Medicine of the National Academies. Weight gain during pregnancy: reexamining the guidelines. Report brief. May 2009. Accessed March 2019. https://bit.ly/34dQKiB

TABLE 2. Fetal and Infant Mortality Risk Based on Maternal BMI

RiskAbsolute risk per 10,000 pregnancies (95% CI)

Maternal BMI = 20 kg per m2 Maternal BMI = 25 kg per m2 Maternal BMI = 30 kg per m2
Fetal death7682 (76 to 88)102 (93 to 112)
Stillbirth4048 (46 to 51)59 (55 to 63)
Perinatal death6673 (67 to 81)86 (76 to 98)
Neonatal death2021 (19 to 23)24 (22 to 27)
Infant death3337 (34 to 39)43 (40 to 47)

BMI = body mass index.

Information from reference 5.

When advising pregnant patients about their diet, physicians should counsel about foods to limit or avoid. Foods such as soft cheeses made from unpasteurized milk, deli meats, sprouts, melons not eaten immediately after cutting, and raw or smoked fish can be contaminated with Listeria monocytogenes. The risk of listeriosis is 18 times higher in patients who are pregnant compared with the general population.7 Other unpasteurized foods such as kefir, kombucha, and kimchi are less well studied. The Centers for Disease Control and Prevention recommends that all unpasteurized foods be avoided during pregnancy to prevent listeriosis.8 The mortality rate of fetal listeriosis is 25% to 35%, depending on the gestational age at the time of infection.7

Vitamins and Supplements

A well-balanced diet rich in vitamin D, folic acid, iron, calcium, omega-3 fatty acids, and other micronutrients should be encouraged for pregnant patients (Table 33,914 ). Prenatal vitamins are recommended because they provide folic acid, iron, calcium, and vitamin D. Ideally, they should be started before conception and should contain at least 400 mcg of folic acid,2,3 30 mg of elemental iron,2,3 200 to 300 mg of calcium,4 and 400 IU of vitamin D.4 Because of the role that vitamin D plays in bone development, the daily recommended intake for patients of childbearing age is 600 IU.9 Vitamin D can be obtained from fortified cereals, pasta, breads, cow's milk, cheese, and yogurt.9 Salmon and eggs are also excellent sources.9 Vitamin D can be synthesized in the skin when exposed to sunlight.9

TABLE 3. Recommended Micronutrients During Pregnancy

MicronutrientRecommended daily intakeCommon amount in prenatal vitamins
Calcium1,000 mg200 to 300 mg
Elemental iron30 mg27 mg
Folic acid400 to 1,000 mcg*600 mcg
Omega-3 fatty acids650 mg0 to 450 mg
Vitamin D600 IU200 to 600 IU

*—4,000 mcg per day recommended for people with a history of neural tube defects.

†—300 mg should be in the form of docosahexaenoic acid.

Information from references 3 and 914.

Calcium is an important part of the prenatal diet. The recommended daily intake is 1,000 mg for people 19 years and older and 1,300 mg for those 14 to 18 years of age.9 Calcium can be obtained from milk and other dairy sources, and it is present in lower concentrations in dark green leafy vegetables.

Pregnant patients should be encouraged to consume two or three servings per week of fish with high levels of omega-3 fatty acids, including docosahexaenoic acid (DHA), which is important for normal eye and brain health in newborns.3,10 Supplementation has been shown to prolong gestation and increase infant size, but natural sources are better than supplements.11 Fish with high mercury content (e.g., swordfish, shark, orange roughy) should be avoided.

Vegetarianism and veganism have increased in popularity over the past several years. Neonatal outcomes in vegetarians or vegans are generally the same as in omnivores, as long as the dietary restrictions are not associated with poverty or limited access to food.12 Supplementation may be required for nutrients that are typically found in animal products, such as vitamins B12 and D.13 All pregnant patients should be encouraged to read the label on their prenatal vitamin to ensure that their daily intake is consistent with guidelines.

Activity

Patients with uncomplicated pregnancies should be encouraged to engage in physical activity and can continue physically demanding occupations with guidance from their physician.15 They may continue their prepregnancy level of exertion as long as it does not include activities with a higher risk of injury and trauma, such as snowboarding or contact sports3,13 (Figure 14,5,1518 ). Exercise recommendations should be individualized during pregnancy and should take into consideration any obstetric complications or preexisting medical conditions3,15 (Table 415,16,19 ). Patients should be encouraged to engage in moderate aerobic activity most days of the week for at least 20 to 30 minutes at a time,15,19 for a total of at least 150 minutes per week.16 Physical activity should also include resistance training.16 A randomized controlled trial showed that yoga during pregnancy improved maternal well-being during the second and third trimesters.20

Figure 1.

Safe and unsafe activities during pregnancy.

Information from references 4, 5, and 1518.

TABLE 4. Contraindications to Aerobic Exercise During Pregnancy

Absolute contraindications
Hemodynamically significant heart disease
Incompetent cervix with or without cerclage
Intrauterine growth restriction*
Multiple gestation at risk of preterm labor
 Higher-order multiples (triplets, etc.)
 Monoamniotic-monochorionic twins
Persistent or unexplained vaginal bleeding
Placenta previa after 26 to 28 weeks' gestation
Preeclampsia or pregnancy-induced hypertension*
Preterm labor
Restrictive lung disease
Ruptured membranes
Severe anemia
Uncontrolled chronic medical conditions
 Hypertension
 Thyroid disease
 Type 1 diabetes mellitus
Relative contraindications
Extreme morbid obesity
Extreme underweight (body mass index < 12 kg per m2) and malnutrition
Heavy smoker
History of extremely sedentary lifestyle
History of preterm labor and birth
Maternal cardiac arrhythmia
Mild or moderate respiratory or cardiovascular disease
Multiple gestation after 28th week
Musculoskeletal conditions
Symptomatic anemia
Uncontrolled medical conditions
 Hyperthyroidism
 Seizure disorders

*—Guideline recommendations for patients with these conditions vary, so these represent the most conservative recommendations.15,16,19

†—Extreme morbid obesity predisposes people to musculoskeletal injury and may indicate poor cardiovascular reserve, so it is important to caution newly pregnant patients and provide detailed information about safe exercise and activity.

‡—Injuries that occur during pregnancy such as back, hip, or other joint strains/sprains; joint pain; or preexisting medical conditions that predispose people to injury (e.g., ankylosing spondylitis, previously stable antero-/retrolisthesis of the lumbar spine).

Information from references 15, 16, and 19.

Heart rate may be blunted during pregnancy and should not be used to assess exercise intensity. Rather, perceived exertion should be used and individualized.15 Regular physical activity during pregnancy can sustain and improve cardiovascular fitness; improve mood; decrease postpartum recovery time; and decrease the risks of gestational diabetes mellitus, excessive weight gain, operative delivery, cesarean delivery, and preeclampsia.15 To prevent thermal injury and maintain euglycemia, pregnant patients should be encouraged to exercise in a temperature-controlled environment, wear loose clothing, maintain hydration, and consume adequate calories before and after exercise.15,16 Clinical guidelines from the National Institute for Occupational Safety and Health recommend weight limits for occupational lifting based on gestational age (see Figure 2 at https://www.ajog.org/article/S0002-9378(13)00242-1/fulltext).21

Swimming and hot tub use can be recommended during pregnancy, but it is not known whether the chemicals used to treat swimming pools and hot tubs affect a developing fetus. A recent study suggested that people who regularly swam in pools during their pregnancies had infants with smaller head circumferences22; however, there was no significant difference in birth weight. The temperature of the water may have more of an impact on fetal development than the chemical exposure. Studies examining heat exposure via hot tubs during early pregnancy showed an increased risk of neural tube defects, esophageal atresia, and omphalocele.23,24 Repeated exposure may increase the risk of these defects.

Bed rest is not recommended for any indication during pregnancy.25 It does not decrease preterm contractions or birth, and it may increase the risk of thrombosis and thromboembolic events.3,25

Medications

One in four pregnant patients 15 to 44 years of age has taken a prescription medication in the past 30 days.26,27 A prospective cohort study found that nearly all participants used medications during their pregnancies: 95% in the first trimester, and 97% at any time.28 Common indications included allergy symptoms, colds, urinary tract infections, gastrointestinal ailments, respiratory disease, cardiovascular disease, and pain.29 The most common over-the-counter medications taken in the first trimester were ibuprofen, acetaminophen, aspirin, naproxen, pseudoephedrine, and docusate.30 Amoxicillin, progesterone, albuterol, progestins, and estrogens were the most commonly taken prescribed medications.30 Generally, first- and second-generation antihistamines, acetaminophen, histamine H2 blockers, and proton pump inhibitors can be used without fetal risk in any trimester.29 Physicians should review the use and safety of other over-the-counter and prescription medications with pregnant patients.

Medication safety during pregnancy has been reported and labeled by the U.S. Food and Drug Administration since 1979.31 In 2015, the agency ended its A, B, C, D, X classification system and now requires data from human and animal studies to be reported narratively 31,32 (Table 529,31,32 ). Labeling for over-the-counter medications has not changed.31,32

TABLE 5. FDA Pregnancy Risk Labeling Information

FDA Pregnancy Risk Categories, 1979 to 2015Pregnancy and Lactation Labeling Rule, 2015 to present*
Category A: Well-controlled studies failed to demonstrate a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters
Category B: Animal studies failed to demonstrate a risk to the fetus, and there are no adequate and well-controlled studies in pregnant patients
Category C: Animal studies demonstrated adverse fetal effects, and there are no adequate and well-controlled studies in humans; the drug should be given only if potential benefits justify potential fetal risks
Category D: There is positive evidence of human fetal risk, but the drug may be acceptable to use if safer drugs are not available or ineffective, or in life-threatening situations despite potential risks
Category X: Studies in animals or humans demonstrated fetal abnormalities, and the risks involved in the use of the drug in pregnant patients clearly outweigh potential benefits; these drugs are contraindicated in people who are pregnant or who could become pregnant
Pregnancy (includes labor and delivery)
 Pregnancy exposure registry
 Risk summary
 Clinical considerations
 Data
Lactation
 Risk summary
 Clinical considerations
 Data
People with reproductive potential
 Pregnancy testing
 Contraception
 Infertility

Note: In 2015, the FDA changed labeling requirements for prescription medications with regards to safety for people who are pregnant or lactating. The changes to drug labeling and package insert information are being made gradually. This table shows how medications were previously labeled and how that information is now being described.

FDA = U.S. Food and Drug Administration.

*—Requires narrative information to improve understanding and shared decision-making.

Information from references 29, 31, and 32.

Sex

Patients undergo constant changes during pregnancy, from their hormone levels to their physical appearance. This can translate to changes in their sex lives. Although some report a lack of libido, others may avoid intercourse for fear of hurting the fetus or experiencing physical discomfort.33 A recent cohort study showed that the frequency and timing of sex had no significant effects on maternal or neonatal outcomes.33 In healthy pregnancies, patients should be encouraged to participate in physical intimacy with their partner if they wish to do so.

Alcohol, Marijuana, Caffeine, Artificial Sweeteners, and Hair Treatments

ALCOHOL

Fetal alcohol spectrum disorder is a well-known complication of excessive fetal alcohol exposure.34 Children born to people who regularly consume more than six drinks per day are at increased risk of this disorder.35 Some studies suggest that even low to moderate consumption of alcohol may have negative effects on fetal development, including reduced length, lower birth weight, and more crying during the first few months of life.36,37 Therefore, alcohol use in any amount during pregnancy should be discouraged.

MARIJUANA

The prevalence of marijuana use is increasing as it is legalized in more states.35,38,39 Intractable nausea and vomiting are indications in many states for prescription of medical marijuana.38 However, given the potential harm to the fetus, it is not recommended to treat nausea and vomiting related to pregnancy. Potential harms include low birth weight and increased risk of admission to neonatal intensive care, and heavy use can be associated with preterm labor.38,39 Marijuana use should be avoided during pregnancy.40

CAFFEINE AND ARTIFICIAL SWEETENERS

Many drinks, such as coffee, tea, and sodas, contain caffeine and artificial sweeteners. Consuming excessive amounts of coffee (more than 350 mg of caffeine per day or about 3.5 cups of coffee) during pregnancy is strongly associated with early pregnancy loss, preterm delivery, and low birth weight.41,42 The American College of Obstetricians and Gynecologists recommends that caffeine intake be limited to 200 mg per day (about two small cups of coffee) during pregnancy.3 Artificial sweeteners are associated with infants who are large for gestational age, and they increase the risk of childhood overweight or obesity.43 Infants who are exposed to artificial sweeteners in utero may be at increased risk of metabolic syndrome when they are older.44

HAIR TREATMENTS

The effects of hair dye or hair straightening products on fetal development and neonatal outcomes are unclear. A Brazilian study found an association between maternal and paternal prenatal exposure and the development of acute lymphocytic leukemia and acute myeloblastic leukemia in children younger than two years.45 Additional research is necessary to definitively recommend for or against the routine use of hair treatments during pregnancy.

Data Sources: A PubMed search was conducted using the key phrases activity restriction in pregnancy, diet in pregnancy, beauty products in pregnancy, pregnancy and swimming pools, pregnancy and hair dye, obesity in pregnancy, vitamin D in pregnancy, drugs in pregnancy, veganism in pregnancy, prenatal care in pregnancy, pregnancy and hot tubs, artificial sweeteners in pregnancy, pregnancy and marijuana, alcohol in pregnancy, caffeine in pregnancy, and sexual intercourse in pregnancy. The search included systematic and clinical reviews, meta-analyses, reviews of clinical trials, evidence-based guidelines, clinical practice guidelines, and prescribing package inserts. We also searched the Cochrane database, the Agency for Healthcare Research and Quality evidence reports, Clinical Evidence, and Essential Evidence Plus. Search dates: March 2019 to March 2020.

The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Army, the Uniformed Services University of the Health Sciences, the Department of Defense, or the U.S. government.

REBECCA CARO, DO, is an assistant professor of family medicine at the Uniformed Services University of the Health Sciences, Bethesda, Md., and a staff physician at Bassett Army Community Hospital, Fort Wainwright, Alaska.

JULIA FAST, DO, is the medical director of Harker Heights (Tex.) Medical Home and an adjunct faculty member at Carl R. Darnall Army Medical Center Family Medicine Residency Program, Fort Hood, Tex.

Published online July 15, 2020.

Address correspondence to Rebecca Caro, DO, 4076 Neely Rd., Fort Wainwright, AK 99703 (email: rebecca.j.caro.mil@mail.mil). Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

  1. 1.Osterman MJK, Martin JA. Timing and adequacy of prenatal care in the United States, 2016. National vital statistics reports. May 30, 2018. Accessed January 25, 2020. https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_03.pdf
  2. 2.Institute of Medicine of the National Academies. Weight gain during pregnancy: reexamining the guidelines. Report brief. May 2009. Accessed March 2019. https://bit.ly/34dQKiB
  3. 3.Fox NS. Dos and don'ts in pregnancy: truths and myths. Obstet Gynecol. 2018;131(4):713-721.
  4. 4.Kilpatrick SJ. Guidelines for Perinatal Care. 8th ed. American Academy of Pediatrics & American College of Obstetricians and Gynecologists; 2017.
  5. 5.Johansson S, Villamor E, Altman M, et al. Maternal overweight and obesity in early pregnancy and risk of infant mortality: a population-based cohort study in Sweden. BMJ. 2014;349:g6572.
  6. 6.ACOG practice bulletin no. 156: obesity in pregnancy [published correction appears in Obstet Gynecol. 2016;128(6):1450]. Obstet Gynecol. 2015;126(6):e112-e126.
  7. 7.Madjunkov M, Chaudhry S, Ito S. Listeriosis during pregnancy. Arch Gynecol Obstet. 2017;296(2):143-152.
  8. 8.Centers for Disease Control and Prevention. Prevent infections during pregnancy. Accessed April 2019. https://www.cdc.gov/features/prenatalinfections/index.html
  9. 9.Ross AC, Taylor CL, Yaktine AK, et al. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011.
  10. 10.Mun JG, Legette LL, Ikonte CJ, et al. Choline and DHA in maternal and infant nutrition: synergistic implications in brain and eye health. Nutrients. 2019;11(5):E1125.
  11. 11.Carlson SE, Colombo J, Gajewski BJ, et al. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013;97(4):808-815.
  12. 12.Piccoli GB, Clari R, Vigotti FN, et al. Vegan-vegetarian diets in pregnancy: danger or panacea? A systematic narrative review. BJOG. 2015;122(5):623-633.
  13. 13.Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician. 2017;96(6):384-389. Accessed January 25, 2020. https://www.aafp.org/afp/2017/0915/p384.html
  14. 14.U.S. Department of Agriculture. Why take a prenatal supplement? Accessed May 13, 2019. https://www.choosemyplate.gov/moms-pregnancy-prenatal-supplements
  15. 15.ACOG committee opinion no. 650: physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol. 2015;126(6):e135-e142.
  16. 16.Mottola MF, Davenport MH, Ruchat SM, et al. 2019 Canadian guideline for physical activity throughout pregnancy. Br J Sports Med. 2018;52(21):1339-1346.
  17. 17.American College of Obstetricians and Gynecologists. FAQ119: exercise during pregnancy. July 2019. Accessed January 25, 2020. https://www.acog.org/Patients/FAQs/Exercise-During-Pregnancy
  18. 18.Davidson C; Society for Maternal-Fetal Medicine. Patient handout: activity restriction in pregnancy. Accessed January 25, 2020. https://www.contemporaryobgyn.net/sites/default/files/legacy/mm/ContemporayOBGYN/SMFM_Handout0814.pdf
  19. 19.Duckitt K. Exercise during pregnancy: eat for one, exercise for two. BMJ. 2011;343:d5710.
  20. 20.Holden SC, Manor B, Zhou J, et al. Prenatal yoga for back pain, balance, and maternal wellness: a randomized, controlled pilot study. Glob Adv Health Med. 2019;8 :2164956119870984.
  21. 21.MacDonald LA, Waters TR, Napolitano PG, et al. Clinical guidelines for occupational lifting in pregnancy: evidence summary and provisional recommendations. Am J Obstet Gynecol. 2013;209(2):80-88.
  22. 22.Salas LA, Baker ER, Nieuwenhuijsen MJ, et al. Maternal swimming pool exposure during pregnancy in relation to birth outcomes and cord blood DNA methylation among private well users. Environ Int. 2019;123:459-466.
  23. 23.Duong HT, Shahrukh Hashmi S, Ramadhani T, et al.; National Birth Defects Prevention Study. Maternal use of hot tub and major structural birth defects. Birth Defects Res A Clin Mol Teratol. 2011;91(9):836-841.
  24. 24.Milunsky A, Ulcickas M, Rothman KJ, et al. Maternal heat exposure and neural tube defects. JAMA. 1992;268(7):882-885.
  25. 25.Habecker E, Sciscione A. Activity restriction in pregnancy. Contemporary OB/GYN. 2014;59(8):34-37.
  26. 26.Hansen C, Interrante JD, Ailes EC, et al. Assessment of YouTube videos as a source of information on medication use in pregnancy. Pharmacoepidemiol Drug Saf. 2016;25(1):35-44.
  27. 27.Centers for Disease Control and Prevention. Research on medicines and pregnancy. Accessed April 2019. http://www.cdc.gov/pregnancy/meds/treatingfortwo/research.html
  28. 28.Haas DM, Marsh DJ, Dang DT, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131(5):789-798.
  29. 29.Servey J, Chang J. Over-the-counter medications in pregnancy [published correction appears in Am Fam Physician. 2015;92(5):332]. Am Fam Physician. 2014;90(8):548-555. Accessed January 25, 2020. https://www.aafp.org/afp/2014/1015/p548.html
  30. 30.Thorpe PG, Gilboa SM, Hernandez-Diaz S, et al.; National Birth Defects Prevention Study. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf. 2013;22(9):1013-1018.
  31. 31.U.S. Food and Drug Administration; Center for Drug Evaluation and Research; Small Business and Industry Assistance. Drugs in pregnancy and lactation: improved benefit-risk information. January 22, 2015. Accessed May 13, 2019. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM431132.pdf
  32. 32.U.S. Food and Drug Administration. Pregnant? Breastfeeding? Better drug information is coming. Updated December 17, 2014. Accessed May 13, 2019. https://www.drugs.com/fda-consumer/pregnant-breastfeeding-better-drug-information-is-coming-334.html
  33. 33.Kong L, Li T, Li L. The impact of sexual intercourse during pregnancy on obstetric and neonatal outcomes: a cohort study in China. J Obstet Gynaecol. 2019;39(4):455-460.
  34. 34.Oei JL. Alcohol use in pregnancy and its impact on the mother and child [published online March 9, 2020]. Addiction. Accessed March 11, 2020. https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15036
  35. 35.Sebastiani G, Borrás-Novell C, Casanova MA, et al. The effects of alcohol and drugs of abuse on maternal nutritional profile during pregnancy. Nutrients. 2018;10(8):E1008.
  36. 36.Sundelin-Wahlsten V, Hallberg G, Helander A. Higher alcohol consumption in early pregnancy or low-to-moderate drinking during pregnancy may affect children's behaviour and development at one year and six months. Acta Paediatr. 2017;106(3):446-453.
  37. 37.Pruett D, Waterman EH, Caughey AB. Fetal alcohol exposure: consequences, diagnosis, and treatment. Obstet Gynecol Surv. 2013;68(1):62-69.
  38. 38.Metz TD, Borgelt LM. Marijuana use in pregnancy and while breastfeeding. Obstet Gynecol. 2018;132(5):1198-1210.
  39. 39.Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: a review of the evidence. Am J Obstet Gynecol. 2015;213(6):761-778.
  40. 40.Bailey BA, Wood DL, Shah D. Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts [published online March 5, 2020]. J Perinatol. Accessed March 11, 2020. https://www.nature.com/articles/s41372-020-0643-z
  41. 41.Li J, Zhao H, Song JM, et al. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. Int J Gynaecol Obstet. 2015;130(2):116-122.
  42. 42.Chen LW, Wu Y, Neelakantan N, et al. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies. Public Health Nutr. 2016;19(7):1233-1244.
  43. 43.Zhu Y, Olsen SF, Mendola P, et al. Maternal consumption of artificially sweetened beverages during pregnancy, and offspring growth through 7 years of age: a prospective cohort study. Int J Epidemiol. 2017;46(5):1499-1508.
  44. 44.Araújo JR, Martel F, Keating E. Exposure to non-nutritive sweeteners during pregnancy and lactation: impact in programming of metabolic diseases in the progeny later in life. Reprod Toxicol. 2014;49:196-201.
  45. 45.Couto AC, Ferreira JD, Rosa AC, et al.; Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal exposure to hair dyes and hair straightening cosmetics, and early age leukemia. Chem Biol Interact. 2013;205(1):46-52.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.